JP2006502171A5 - - Google Patents

Download PDF

Info

Publication number
JP2006502171A5
JP2006502171A5 JP2004535464A JP2004535464A JP2006502171A5 JP 2006502171 A5 JP2006502171 A5 JP 2006502171A5 JP 2004535464 A JP2004535464 A JP 2004535464A JP 2004535464 A JP2004535464 A JP 2004535464A JP 2006502171 A5 JP2006502171 A5 JP 2006502171A5
Authority
JP
Japan
Prior art keywords
diseases
substance
disorders
certain
iritis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004535464A
Other languages
English (en)
Japanese (ja)
Other versions
JP4564846B2 (ja
JP2006502171A (ja
Filing date
Publication date
Priority claimed from GBGB0220953.4A external-priority patent/GB0220953D0/en
Application filed filed Critical
Publication of JP2006502171A publication Critical patent/JP2006502171A/ja
Publication of JP2006502171A5 publication Critical patent/JP2006502171A5/ja
Application granted granted Critical
Publication of JP4564846B2 publication Critical patent/JP4564846B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2004535464A 2002-09-10 2003-09-09 アロイル−ピペリジン誘導体 Expired - Fee Related JP4564846B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0220953.4A GB0220953D0 (en) 2002-09-10 2002-09-10 Organic compounds
PCT/EP2003/010007 WO2004024714A1 (en) 2002-09-10 2003-09-09 Aroyl-piperidine derivatives

Publications (3)

Publication Number Publication Date
JP2006502171A JP2006502171A (ja) 2006-01-19
JP2006502171A5 true JP2006502171A5 (cg-RX-API-DMAC7.html) 2006-10-26
JP4564846B2 JP4564846B2 (ja) 2010-10-20

Family

ID=9943781

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004535464A Expired - Fee Related JP4564846B2 (ja) 2002-09-10 2003-09-09 アロイル−ピペリジン誘導体

Country Status (9)

Country Link
US (2) US7678814B2 (cg-RX-API-DMAC7.html)
EP (1) EP1539737A1 (cg-RX-API-DMAC7.html)
JP (1) JP4564846B2 (cg-RX-API-DMAC7.html)
CN (1) CN1681803A (cg-RX-API-DMAC7.html)
AU (1) AU2003273398A1 (cg-RX-API-DMAC7.html)
BR (1) BR0314164A (cg-RX-API-DMAC7.html)
CA (1) CA2498285C (cg-RX-API-DMAC7.html)
GB (1) GB0220953D0 (cg-RX-API-DMAC7.html)
WO (1) WO2004024714A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0220953D0 (en) * 2002-09-10 2002-10-23 Novartis Ag Organic compounds
JP2010519312A (ja) * 2007-02-23 2010-06-03 アベラ ファーマシューティカルズ, インコーポレイテッド 薬学的製剤
WO2013004766A1 (en) 2011-07-04 2013-01-10 Ferrari Giulio Nk-1 receptor antagonists for treating corneal neovascularisation
RU2020131446A (ru) 2018-02-26 2022-03-28 Оспедале Сан Раффаэле С.Р.Л. Антагонисты nk-1 для применения в лечении глазной боли
EP4117673A1 (en) 2020-03-11 2023-01-18 Ospedale San Raffaele S.r.l. Treatment of stem cell deficiency

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6115A (ja) * 1984-06-12 1986-01-06 Kyowa Hakko Kogyo Co Ltd リポキシゲナ−ゼ代謝産物に起因する疾患の予防治療剤
MY110227A (en) * 1991-08-12 1998-03-31 Ciba Geigy Ag 1-acylpiperindine compounds.
TW397825B (en) 1994-10-14 2000-07-11 Novartis Ag Aroyl-piperidine derivatives
RU2156250C2 (ru) 1995-04-24 2000-09-20 Новартис Аг Производные хромона, способ их получения и фармацевтическая композиция
WO1997045119A1 (en) 1996-05-24 1997-12-04 Novartis Ag Use of substance p antagonists for treating social phobia
TW537894B (en) 1998-05-26 2003-06-21 Novartis Ag A spontaneously dispersible pharmaceutical composition comprising a piperidine substance P antagonist
WO2000010545A2 (en) 1998-08-25 2000-03-02 Novartis Ag Use of substance p antagonists for the treatment of chronic fatigue syndrome and/or fibromyalgia and use of nk-1 receptor antagonists for the treatment of chronic fatigue syndrome
JP3930428B2 (ja) * 2000-08-09 2007-06-13 エフ.ホフマン−ラ ロシュ アーゲー 抗炎症剤としてのキノリン誘導体
JP2002220386A (ja) * 2000-10-02 2002-08-09 Tanabe Seiyaku Co Ltd ベンジルアミン誘導体、その製法およびその合成中間体
GB0220953D0 (en) * 2002-09-10 2002-10-23 Novartis Ag Organic compounds

Similar Documents

Publication Publication Date Title
TW200628472A (en) Piperidinylamino-thieno (2,3-d) pyrimidine compounds
ATE488496T1 (de) Histamin-3-rezeptorantagonisten
MY147442A (en) Imidazoquinolines as lipid kinase inhibitors
WO2007063385A3 (en) Spirocyclic amine histamine-3 receptor antagonists
UA99309C2 (ru) Замещенные пиперидинодигидротиенопиримидины
NO20050164L (no) Nye quinuklidin-amid-derivater
NO20074615L (no) Dihydrotienopyrimidiner for behandling av inflamatoriske sykdommer
RS52526B2 (sr) Derivati oksadiazola i njihovo korišćenje kao potencijatora metabotropnih glutamatnih receptora-842
EA200802051A1 (ru) Дигидротиенопиримидины для лечения воспалительных заболеваний
EP2075064A4 (en) SWAP LAYER CATALYST FOR THE PREPARATION OF ACRYLNITRILE AND METHOD FOR THE PRODUCTION OF ACRYLNITRILE
EA200100124A1 (ru) Замещенные 1,8-нафтиридин-4(1h)-оны в качестве ингибиторов фосфодиэстеразы 4
WO2009003868A3 (en) 2 -imidazolines having a good affinity to the trace amine associated receptors (taars)
JP2009543825A5 (cg-RX-API-DMAC7.html)
DE502005010170D1 (de) Neue langwirksame beta-2-agonisten, und deren verwendung als arzneimittel
US20180078548A1 (en) Methods for Treating Central Nervous System Disorders Using VDAC Inhibitors
ATE475640T1 (de) Antagonisten des opioidrezeptors
JP2007516278A5 (cg-RX-API-DMAC7.html)
Butora et al. 3-Amino-1-alkyl-cyclopentane carboxamides as small molecule antagonists of the human and murine CC chemokine receptor 2
NO20074617L (no) Nye forbindelser for behandling av inflamotoriske sykdommer
WO2005105092A3 (en) 3,3-disubstituted tetrahydropyranyl cyclopentyl amide modulators of chemokine receptor activity
WO2009064836A3 (en) Kynurenine-aminotransferase inhibitors
JP2005527477A5 (cg-RX-API-DMAC7.html)
JP2008516909A5 (cg-RX-API-DMAC7.html)
WO2009078432A1 (ja) 1-アルキル-4-アミノ-1h-ピラゾール-3-カルボキサミド化合物
MX2010009403A (es) Derivados de 2-aminoquinolina.